-
Je něco špatně v tomto záznamu ?
Asymmetry of VANGL2 in migrating lymphocytes as a tool to monitor activity of the mammalian WNT/planar cell polarity pathway
M. Kaucká, J. Petersen, P. Janovská, T. Radaszkiewicz, L. Smyčková, AM. Daulat, JP. Borg, G. Schulte, V. Bryja,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT11217
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
BioMedCentral
od 2003-12-01
BioMedCentral Open Access
od 2003
Directory of Open Access Journals
od 2003
Free Medical Journals
od 2003
PubMed Central
od 2003
Europe PubMed Central
od 2003
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2003-01-01
Open Access Digital Library
od 2003-08-01
Open Access Digital Library
od 2003-01-01
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2003
Springer Nature OA/Free Journals
od 2003-12-01
- MeSH
- B-lymfocyty metabolismus patologie MeSH
- chronická lymfatická leukemie genetika imunologie patologie MeSH
- intracelulární signální peptidy a proteiny genetika imunologie MeSH
- lidé MeSH
- membránové proteiny genetika imunologie MeSH
- nádorové buněčné linie MeSH
- pohyb buněk genetika imunologie MeSH
- polarita buněk genetika imunologie MeSH
- signální dráha Wnt genetika imunologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: The WNT/planar-cell-polarity (PCP) pathway is a key regulator of cell polarity and directional cell movements. Core PCP proteins such as Van Gogh-like2 (VANGL2) are evolutionarily highly conserved; however, the mammalian PCP machinery is still poorly understood mainly due to lack of suitable models and quantitative methodology. WNT/PCP has been implicated in many human diseases with the most distinguished positive role in the metastatic process, which accounts for more than 90% of cancer related deaths, and presents therefore an attractive target for pharmacological interventions. However, cellular assays for the assessment of PCP signaling, which would allow a more detailed mechanistic analysis of PCP function and possibly also high throughput screening for chemical compounds targeting mammalian PCP signaling, are still missing. RESULTS: Here we describe a mammalian cell culture model, which correlates B lymphocyte migration of patient-derived MEC1 cells and asymmetric localization of fluorescently-tagged VANGL2. We show by live cell imaging that PCP proteins are polarized in MEC1 cells and that VANGL2 polarization is controlled by the same mechanism as in tissues i.e. it is dependent on casein kinase 1 activity. In addition, destruction of the actin cytoskeleton leads to migratory arrest and cell rounding while VANGL2-EGFP remains polarized suggesting that active PCP signaling visualized by polarized distribution of VANGL2 is a cause for and not a consequence of the asymmetric shape of a migrating cell. CONCLUSIONS: The presented imaging-based methodology allows overcoming limitations of earlier approaches to study the mammalian WNT/PCP pathway, which required in vivo models and analysis of complex tissues. Our system investigating PCP-like signaling on a single-cell level thus opens new possibilities for screening of compounds, which control asymmetric distribution of proteins in the PCP pathway.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031486
- 003
- CZ-PrNML
- 005
- 20170413135752.0
- 007
- ta
- 008
- 151005s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12964-014-0079-1 $2 doi
- 035 __
- $a (PubMed)25627785
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kaucká, Markéta $7 _AN068807 $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
- 245 10
- $a Asymmetry of VANGL2 in migrating lymphocytes as a tool to monitor activity of the mammalian WNT/planar cell polarity pathway / $c M. Kaucká, J. Petersen, P. Janovská, T. Radaszkiewicz, L. Smyčková, AM. Daulat, JP. Borg, G. Schulte, V. Bryja,
- 520 9_
- $a BACKGROUND: The WNT/planar-cell-polarity (PCP) pathway is a key regulator of cell polarity and directional cell movements. Core PCP proteins such as Van Gogh-like2 (VANGL2) are evolutionarily highly conserved; however, the mammalian PCP machinery is still poorly understood mainly due to lack of suitable models and quantitative methodology. WNT/PCP has been implicated in many human diseases with the most distinguished positive role in the metastatic process, which accounts for more than 90% of cancer related deaths, and presents therefore an attractive target for pharmacological interventions. However, cellular assays for the assessment of PCP signaling, which would allow a more detailed mechanistic analysis of PCP function and possibly also high throughput screening for chemical compounds targeting mammalian PCP signaling, are still missing. RESULTS: Here we describe a mammalian cell culture model, which correlates B lymphocyte migration of patient-derived MEC1 cells and asymmetric localization of fluorescently-tagged VANGL2. We show by live cell imaging that PCP proteins are polarized in MEC1 cells and that VANGL2 polarization is controlled by the same mechanism as in tissues i.e. it is dependent on casein kinase 1 activity. In addition, destruction of the actin cytoskeleton leads to migratory arrest and cell rounding while VANGL2-EGFP remains polarized suggesting that active PCP signaling visualized by polarized distribution of VANGL2 is a cause for and not a consequence of the asymmetric shape of a migrating cell. CONCLUSIONS: The presented imaging-based methodology allows overcoming limitations of earlier approaches to study the mammalian WNT/PCP pathway, which required in vivo models and analysis of complex tissues. Our system investigating PCP-like signaling on a single-cell level thus opens new possibilities for screening of compounds, which control asymmetric distribution of proteins in the PCP pathway.
- 650 _2
- $a B-lymfocyty $x metabolismus $x patologie $7 D001402
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a pohyb buněk $x genetika $x imunologie $7 D002465
- 650 _2
- $a polarita buněk $x genetika $x imunologie $7 D016764
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intracelulární signální peptidy a proteiny $x genetika $x imunologie $7 D047908
- 650 _2
- $a chronická lymfatická leukemie $x genetika $x imunologie $x patologie $7 D015451
- 650 _2
- $a membránové proteiny $x genetika $x imunologie $7 D008565
- 650 _2
- $a signální dráha Wnt $x genetika $x imunologie $7 D060449
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Petersen, Julian
- 700 1_
- $a Janovská, Pavlína $7 mub20211103818 $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Radaszkiewicz, Tomasz $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Smyčková, Lucie $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Daulat, Avais M
- 700 1_
- $a Borg, Jean-Paul
- 700 1_
- $a Schulte, Gunnar $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Bryja, Vítězslav, $d 1977- $7 xx0035073 $u Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
- 773 0_
- $w MED00008216 $t Cell communication and signaling CCS $x 1478-811X $g Roč. 13, č. - (2015), s. 2
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25627785 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20170413140053 $b ABA008
- 999 __
- $a ok $b bmc $g 1092362 $s 914612
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 13 $c - $d 2 $e 20150128 $i 1478-811X $m Cell communication and signaling $n Cell Commun Signal $x MED00008216
- GRA __
- $a NT11217 $p MZ0
- LZP __
- $a Pubmed-20151005